A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic Hypoparathyroidism
Status:
Not yet recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
This clinical study aims to evaluate the safety and efficacy of repeated dosing of
recombinant human parathyroid hormone (rhPTH[1-84]) in Japanese participants with chronic
hypoparathyroidism for a 26-week period.